EcoDrugPlus

Ensembl ID : ENSDLAG00005004899
Gene Symbol: -
Cross references: -
214 Possible Orthologues:

Ensembl ID : ENSDLAG00005004960
Gene Symbol: -
Cross references: -
229 Possible Orthologues:

Ensembl ID : ENSDLAG00005005016
Gene Symbol: -
Cross references: -
252 Possible Orthologues:

Ensembl ID : ENSDLAG00005005145
Gene Symbol: -
Cross references: -
221 Possible Orthologues:

Ensembl ID : ENSDLAG00005006199
Gene Symbol: -
Cross references: -
174 Possible Orthologues:

Ensembl ID : ENSDLAG00005006654
Gene Symbol: -
Cross references: -
194 Possible Orthologues:

Ensembl ID : ENSDLAG00005006666
Gene Symbol: -
Cross references: -
214 Possible Orthologues:

Ensembl ID : ENSDLAG00005006674
Gene Symbol: -
Cross references: -
212 Possible Orthologues:

Ensembl ID : ENSDLAG00005006690
Gene Symbol: -
Cross references: -
197 Possible Orthologues:

Ensembl ID : ENSDLAG00005006755
Gene Symbol: -
Cross references: -
196 Possible Orthologues:

Ensembl ID : ENSDLAG00005006971
Gene Symbol: -
Cross references: -
182 Possible Orthologues:

Ensembl ID : ENSDLAG00005007001
Gene Symbol: -
Cross references: -
190 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).